Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Brizot 2001.

Clinical features and settings Routine screening
Participants 2996 participants
Brazil ‐ University Hospital
Estimated date of delivery pre December 1999
Pregnant women
Median age 28 years (13‐46 years), 19.4% ≥ 35 years
Singleton pregnancies
10‐14 weeks' gestation (mean 12 weeks)
Study design Prospective cohort
Target condition and reference standard(s) Down's syndrome: 10 cases
Reference standards: antenatal karyotyping (5.9% of pregnancies: 62% of high‐risk, 29% of medium‐risk and 3% of the low‐risk women) or follow‐up to birth (85.3% of women)
Index and comparator tests Maternal age
First trimester (10‐14 weeks) NT
Risk cut‐off 1:300
Follow‐up 85.3% of women were followed up to birth. Of these, 65 were spontaneous miscarriages or intrauterine death with no karyotyping
Aim of study To assess the detection rate of chromosomal abnormalities using NT
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population 
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Unclear Unclear if all women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice 
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements
Withdrawals explained? 
 All tests No No details of withdrawals given